Research suggests that black elderberry extract may have antimicrobial and antiviral properties relevant to respiratory infections, with laboratory studies indicating it can inhibit the growth of certain bacteria associated with upper respiratory illness, such as Streptococcus pyogenes, as well as reduce the replication of influenza A and B viruses in cell culture experiments. The available evidence in this summary is limited to a single in vitro study using a standardized elderberry liquid extract, meaning findings reflect controlled laboratory conditions rather than outcomes observed in human patients. Studies of this type are useful for identifying biological plausibility but cannot confirm whether these effects translate to meaningful clinical benefit in people with colds or flu. Readers interested in elderberry for cold and flu support should be aware that the current evidence base, at least as represented here, does not yet include clinical trials, and broader conclusions should await findings from human studies.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Inhibitory activity of a standardized elderberry liquid extract against clini... | Other | 2011 | Supports | 72 |